Last Updated: May 6, 2026

KETAMINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Ketamine, and what generic alternatives are available?

Ketamine is a drug marketed by Caplin, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Hospira, and Baxter Hlthcare Corp. and is included in seven NDAs.

The generic ingredient in KETAMINE is ketamine hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ketamine

A generic version of KETAMINE was approved as ketamine hydrochloride by HIKMA on March 22^nd, 1996.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for KETAMINE?
What are the global sales for KETAMINE?
What is Average Wholesale Price for KETAMINE?

Summary for KETAMINE

US Patents:	0
Applicants:	7
NDAs:	7
Drug Prices:	Drug price information for KETAMINE
DailyMed Link:	KETAMINE at DailyMed

Drug patent expirations by year for KETAMINE

Drug Prices for KETAMINE

US Patents and Regulatory Information for KETAMINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Caplin	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	217858-001	Aug 7, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fresenius Kabi Usa	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	215808-003	Apr 18, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Eugia Pharma	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	076092-003	Oct 25, 2002	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	074524-002	Mar 22, 1996	AP	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Gland	KETAMINE HYDROCHLORIDE	ketamine hydrochloride	INJECTABLE;INJECTION	216809-001	Jan 24, 2023	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.